Radiomics Signature Facilitates Organ-Saving Strategy in Patients With Esophageal Squamous Cell Cancer Receiving Neoadjuvant Chemoradiotherapy

After neoadjuvant chemoradiotherapy (NCRT) in locally advanced esophageal squamous cell cancer (ESCC), roughly 40% of the patients may achieve pathologic complete response (pCR). Those patients may benefit from organ-saving strategy if the probability of pCR could be correctly identified before esop...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Li, Yue, Liu, Jun, Li, Hong-xuan, Cai, Xu-wei, Li, Zhi-gang, Ye, Xiao-dan, Teng, Hao-hua, Fu, Xiao-long, Yu, Wen
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933499/
https://ncbi.nlm.nih.gov/pubmed/33680935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.615167
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky